lidocaine has been researched along with HIV-Associated Lipodystrophy Syndrome in 2 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rotunda, AM | 1 |
| Jones, DH | 1 |
| Susman, E | 1 |
2 other studies available for lidocaine and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Human immunodeficiency virus-associated lipohypertrophy (buccal fat pad lipoma-like lesions) reduced with subcutaneously injected sodium deoxycholate.
Topics: Anesthetics, Local; Cheek; Deoxycholic Acid; HIV-Associated Lipodystrophy Syndrome; Humans; Injectio | 2010 |
Notes from the XIV International AIDS Conference in Barcelona, Spain.
Topics: Acquired Immunodeficiency Syndrome; Administration, Cutaneous; Anesthetics, Local; Anti-HIV Agents; | 2002 |